Enteral Feeding Formulas Market To Reach $10.52 Billion By 2030

Enteral Feeding Formulas Market Growth & Trends

The global enteral feeding formulas market size is expected to reach USD 10.52 billion by 2030, registering a CAGR of 5.43% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidences of targeted diseases and advancements in drug development are expected to drive the demand for disease-specific formulas. Clinical nutrition is increasingly used for the personalized treatment of diseases, such as cancer and cystic fibrosis. These conditions require special nutrition to avoid any kind of drug interaction.

For instance, in the case of cystic fibrosis, special digestive enzyme capsules are administered. The nature of these digestive enzymes can vary in individuals. Appropriate nutrition is critical for preterm infants, and early nutrition provision could influence better clinical outcomes & growth of the child, including neurodevelopment, decreased risk of Retinopathy of Prematurity (ROP), or prevention of Bronchopulmonary Dysplasia (BPD).

The commitment of NPOs and NGOs to preventing and caring for preterm birth, such as the ‘Every Woman Every Child’ movement of the UN, to advance the global strategy on women’s and children's health, is expected to boost the demand for neonatal & preterm enteral feeding formulas. Growing initiatives to spread awareness regarding the importance of nutrients among the patient population are expected to improve the current market scenario.

According to an article titled ASPEN Strives to Address Critical Gaps in Diagnoses, Care, and Treatment through Annual Malnutrition Awareness Week, published by ASPEN, around 10 hospitalized patients go undiagnosed every 60 seconds. Hence, this organization established Malnutrition Awareness Week in 2011 to spread awareness regarding malnutrition in hospitalized patients and educate healthcare professionals on the importance of nutrients among patients.

In case of medical necessity, Medicaid must cover enteral nutrition. However, there are no such regulations/mandates on private insurance companies. Moreover, as per the results of a survey conducted by NCBI, there is a huge lack of reimbursement for patients on Home Enteral Nutrition (HEN) and inadequate awareness among stakeholders regarding market opportunities, especially in lower-income countries.

 Request a free sample copy or view report summary: Enteral Feeding Formulas Market Report

Enteral Feeding Formulas Market Report Highlights

• The standard formula segment led the market with the largest revenue share of 53.7% in 2024. The disease-specific formulas segment is expected to grow at the fastest CAGR during the forecast period.

• The intermittent feeding flow segment accounted for the largest revenue share in 2024. The continuous feeding flow segment is anticipated to grow at the fastest CAGR during the forecast period.

• The adult segment accounted for the largest market revenue share in 2024. The adult segment is also projected to grow at the fastest CAGR during the forecast period.

• The cancer care segment accounted for the largest market revenue share in 2024. The other indications segment is expected to grow at the fastest CAGR over the forecast period.

• The institutional sales segment accounted for the largest market revenue share in 2024. The online sales channel segment is projected to grow at the fastest CAGR over the forecast period.

• The home care segment accounted for the largest market revenue share in 2024. The hospital segment is anticipated to grow at the fastest CAGR during the forecast period.

Enteral Feeding Formulas Market Segmentation

Grand View Research has segmented global enteral feeding formulas market report based on product, flow type, stage, indication, end-user, sales channel, and region:

Enteral Feeding Formulas Product Outlook (Revenue, USD Million, 2018 - 2030)

• Standard Formula

• Disease-specific Formulas

  • Alzheimer’s

  • Nutrition Deficiency

  • Cancer Care

  • Diabetes

  • Chronic Kidney Diseases

  • Orphan Diseases

  • Dysphagia

  • Pain Management

  • Malabsorption/GI Disorder/Diarrhea

  • Others

Enteral Feeding Formulas Flow Type Outlook (Revenue, USD Million, 2018 - 2030)

• Intermittent Feeding Flow

• Continuous Feeding Flow

Enteral Feeding Formulas Stage Outlook (Revenue, USD Million, 2018 - 2030)

• Adults

• Pediatrics

Enteral Feeding Formulas Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Alzheimer’s

• Nutrition Deficiency

• Cancer Care

• Diabetes

• Chronic Kidney Diseases

• Orphan Diseases

• Dysphagia

• Pain Management

• Malabsorption/GI Disorder/Diarrhea

• Others

Enteral Feeding Formulas End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

  • Cardiology

  • Neurology

  • Critical Care (ICU)

  • Oncology

  • Others

• Home Care

Enteral Feeding Formulas Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Online Sales

• Retail Sales

• Institutional Sales

Enteral Feeding Formulas Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Spain

  • Italy

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List Of Key Players Enteral Feeding Formulas Market

• Abbott

• Danone S.A

• Fresenius Kabi AG

• Nestlé

• VICTUS

• Primus Pharmaceuticals, Inc.

• Meiji Holdings. Co., Ltd.

• Mead Johnson & Company, LLC

• Alcresta Therapeutics